FUMAGALLI, FRANCESCA
FUMAGALLI, FRANCESCA
DIPARTIMENTO DI SCIENZE FARMACOLOGICHE (attivo dal 01/01/2001 al 27/04/2012)
Duration of Untreated Cardiac Arrest and Clinical Relevance of Animal Experiments : The Relationship Between the “No-Flow” Duration and the Severity of Post-Cardiac Arrest Syndrome in a Porcine Model
2018 G. Babini, L.G. Grassi, I. Russo, D. Novelli, A. Boccardo, A. Luciani, F. Fumagalli, L. Staszewsky, F. Fiordaliso, M. de Maglie, M. Salio, D.D. Zani, T. Letizia, S. Masson, M.V. Luini, D. Pravettoni, E. Scanziani, R. Latini, G. Ristagno
Postresuscitation Treatment With Argon Improves Early Neurological Recovery in a Porcine Model of Cardiac Arrest
2014 G. Ristagno, F. Fumagalli, I. Russo, S. Tantillo, D.D. Zani, V. Locatelli, M. De Maglie, D. Novelli, L. Staszewsky, T. Vago, A. Belloli, M. Di Giancamillo, M. Fries, S. Masson, E. Scanziani, R. Latini
Bronchodilators Modulate Inflammation In Chronic Obstructive Pulmonary Disease Subjects
2012 P. Santus, C. Buccellati, S. Centanni, F. Fumagalli, P. Busatto, F. Blasi, A. Sala
Hydroxytyrosol attenuates peripheral neuropathy in streptozotocin-induced diabetes in rats
2012 G. Ristagno, F. Fumagalli, C. Porretta-serapiglia, A. Orrã¹, C. Cassina, M. Pesaresi, S. Masson, L. Villanova, A. Merendino, A. Villanova, L. Cervo, G. LAURIA PINTER, R. Latini, R. Bianchi
The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1, 3-benzenedicarboxamide](2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculature
2012 I. Brivio, C. Buccellati, F. Fumagalli, J. Hodge, C. Casagrande, G. Folco, A. Sala
Biomarkers of inflammation and oxidative stress in patients with COPD and healthy smokers
2010 P. Montuschi, M. Aiello, C. Buccellati, G. Ciabattoni, A. Chetta, E. Clini, G. Folco, F. Fumagalli, M. Losi, D. Olivieri, R. Pisi, R. Shohreh, A. Sala
A new class of nitric oxide-releasing derivatives of cetirizine; pharmacological profile in vascular and airway smooth muscle preparations
2007 A.K. Larsson, F. Fumagalli, A. Di Gennaro, M. Andersson, J. Lundberg, C. Edenius, M. Govoni, A. Monopoli, A. Sala, S.E. Dahlen, G.C. Folco
From field to health : a simple way to increase the nutraceutical content of grape ss shown by NO-Dependent vascular relaxation
2006 F. Fumagalli, M. Rossoni, M. Iriti, A. Di Gennaro, F. Faoro, E. Borroni, M. Borgo, A. Scienza, A. Sala, G. Folco
Lipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary disease
2005 P. Santus, A. Sola, P. Carlucci, F. Fumagalli, A. Di Gennaro, M. Mondoni, C. Carnini, S. Centanni, A. Sala
Leukotriene synthesis and lipid peroxidation in COPD subjects
2004 A. Sola, P. Santus, F. Fumagalli, A. Di Gennaro, C. Carnini, S. Centanni, A. Sala
5-Lipoxygenase activity, lipid peroxidation and the effect of antioxidant treatment in COPD subjects
2004 A. Sala, P. Santus, A. Sola, F. Fumagalli, A. Di Gennaro, C. Carnini, S. Centanni
Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes.
2004 A. Di Gennaro, C. Carnini, C. Buccellati, R. Ballerio, S. Zarini, F. Fumagalli, S. Viappiani, L. Librizzi, A. Hernandez, R.C. Murphy, G. Constantin, M. De Curtis, G. Folco, A. Sala
Antioxidant modulation of cyclooxygenase-2 in human bronchial smooth muscle cells
2002 F. Fumagalli, A. Bonazzi, F. Visioli, A.N. Hernandez, G. Folco, A. Sala
Leukotriene modifiers: novel therapeutic opportunities in asthma
2002 C. Buccellati, F. Fumagalli, S. Viappiani, G. Folco